FDA Approved: ERTAPENEM — Supplemental Application (Apotex Corp)

View source ↗

Summary

FDA approved a supplemental application for Apotex Corp to market ertapenem sodium (ERTAPENEM) as a generic antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Intra-abdominal Infections
• Pelvic Inflammatory Disease
• Skin and Skin Structure Infections

Drugs mentioned

• ERTAPENEM (ertapenem)

Snippet

SUPPL AP for ERTAPENEM (ERTAPENEM SODIUM)